SG Americas Securities’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,403
| Closed | -$316K | – | 3642 |
|
|
2021
Q4 | $316K | Sell |
3,403
-11,166
| -77% | -$736K | ﹤0.01% | 2412 |
|
|
2021
Q3 | $868K | Buy |
14,569
+4,123
| +39% | +$244K | ﹤0.01% | 2029 |
|
|
2021
Q2 | $712K | Buy |
10,446
+4,542
| +77% | +$296K | ﹤0.01% | 1762 |
|
|
2021
Q1 | $410K | Buy |
5,904
+4,191
| +245% | +$322K | ﹤0.01% | 2155 |
|
|
2020
Q4 | $132K | Sell |
1,713
-17,322
| -91% | -$1.3M | ﹤0.01% | 2899 |
|
|
2020
Q3 | $1.42M | Sell |
19,035
-34,422
| -64% | -$2.29M | 0.01% | 984 |
|
|
2020
Q2 | $3.37M | Sell |
53,457
-3,292
| -6% | -$181K | 0.03% | 532 |
|
|
2020
Q1 | $2.38M | Buy |
56,749
+33,628
| +145% | +$1.54M | 0.02% | 708 |
|
|
2019
Q4 | $1.05M | Sell |
23,121
-15,145
| -40% | -$716K | 0.01% | 1230 |
|
|
2019
Q3 | $1.75M | Buy |
38,266
+35,744
| +1,417% | +$2.01M | 0.01% | 1050 |
|
|
2019
Q2 | $148K | Sell |
2,522
-21,575
| -90% | -$1.12M | ﹤0.01% | 2584 |
|
|
2019
Q1 | $1.08M | Buy |
24,097
+13,042
| +118% | +$598K | 0.01% | 1234 |
|
|
2018
Q4 | $431K | Buy |
+11,055
| New | +$434K | ﹤0.01% | 1966 |
|
|
2018
Q3 | – | Sell |
-5,872
| Closed | -$256K | – | 3560 |
|
|
2018
Q2 | $256K | Sell |
5,872
-1,904
| -24% | -$81.8K | ﹤0.01% | 2443 |
|
|
2018
Q1 | $307K | Buy |
+7,776
| New | +$302K | ﹤0.01% | 2164 |
|
|
2017
Q3 | – | Sell |
-7,349
| Closed | -$124K | – | 3811 |
|
|
2017
Q2 | $124K | Buy |
7,349
+5,419
| +281% | +$74.3K | ﹤0.01% | 2769 |
|
|
2017
Q1 | $28K | Sell |
1,930
-7,962
| -80% | -$118K | ﹤0.01% | 3167 |
|
|
2016
Q4 | $140K | Buy |
9,892
+2,870
| +41% | +$44.5K | ﹤0.01% | 2627 |
|
|
2016
Q3 | $123K | Buy |
7,022
+2,318
| +49% | +$38.4K | ﹤0.01% | 2902 |
|
|
2016
Q2 | $80K | Buy |
4,704
+2,970
| +171% | +$53.1K | ﹤0.01% | 2419 |
|
|
2016
Q1 | $34K | Buy |
1,734
+314
| +22% | +$5.03K | ﹤0.01% | 2794 |
|
|
2015
Q4 | $27K | Sell |
1,420
-1,167
| -45% | -$23.8K | ﹤0.01% | 2533 |
|
|
2015
Q3 | $49K | Sell |
2,587
-665
| -20% | -$22.6K | ﹤0.01% | 1964 |
|
|
2015
Q2 | $151K | Sell |
3,252
-1,931
| -37% | -$83.8K | ﹤0.01% | 2124 |
|
|
2015
Q1 | $226K | Sell |
5,183
-6,379
| -55% | -$296K | ﹤0.01% | 1818 |
|
|
2014
Q4 | $401K | Buy |
11,562
+7,989
| +224% | +$324K | ﹤0.01% | 1826 |
|
|
2014
Q3 | $150K | Buy |
3,573
+2,018
| +130% | +$90.1K | ﹤0.01% | 2150 |
|
|
2014
Q2 | $91K | Buy |
+1,555
| New | +$97.9K | ﹤0.01% | 2352 |
|
|
2014
Q1 | – | Sell |
-6,327
| Closed | -$370K | – | 2860 |
|
|
2013
Q4 | $370K | Sell |
6,327
-9,508
| -60% | -$497K | ﹤0.01% | 1714 |
|
|
2013
Q3 | $835K | Sell |
15,835
-3,221
| -17% | -$216K | ﹤0.01% | 1365 |
|
|
2013
Q2 | $1.47M | Buy |
+19,056
| New | +$1.56M | 0.01% | 886 |
|
SG Americas Securities's ARNA Position: Q1 2022 in Review
SG Americas Securities sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 3,403 shares — an estimated $316K sold.
SG Americas Securities first reported a position in ARNA in Q2 2013 and held it in 31 quarters. The position peaked at $3.37M in Q2 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- SG Americas Securities reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- SG Americas Securities sold 3,403 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $316K.
- SG Americas Securities first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 31 quarters.
- SG Americas Securities's Arena Pharmaceuticals Inc position peaked at $3.37M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.